Search results for: NICE
Filter search results
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…is why alternative HTA criteria for treatments for very rare diseases have been applied through special evaluation routes, such as NICE’s Highly Specialised Technology pathway – whether those criteria are…
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…of Health and Care Excellence (NICE), and when it is considered, the data are often much poorer than equivalent outcomes data for patients ( Pennington, 2020). There are also important…
Around The World in HTAs: Spain – Are We There Yet?
15 March 2023
…our blog about ‘HispaNICE’) The second step is to identify the long-term objectives and to design a road map towards it. This could allow the Spanish system, still in its…
A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
19 May 2023
…such as the NICE-NHS England pilot in the UK and the PASTEUR Act in the US, is a moment of opportunity to redefine how health technologies with a large impact…
The US Inflation Reduction Act: What Do the Experts Think?
25 May 2023
…key takeaways from the thought leaders at the conference. Why is everyone talking about it? The scene was set at ISPOR’s opening plenary NICE’s Chief Executive, Dr Samantha Roberts, set…
Shalu Jain
29 June 2023
…Authority, Department of Health Research, Ministry of Health and Family Welfare. She also works with multiple international organisations on different projects like NICE-UK, HITAP-Thailand, The EuroQoL Foundation-The Netherlands, Deutsche Gesellschaft…
Christopher Henshall
30 August 2023
…in England (where as Under Secretary he was involved in establishing the NHS R&D Budget, the NHS HTA Programme and the National Institute for Health and Care Excellence – NICE),…
Lung Cancer’s Biggest Test: How Can We Mobilise NGS Testing to Transform Lung Cancer Care?
7 December 2023, 12:00am
…access to personalized medicines and combination medicines. She has expertise in market access and HTA, leading multiple submissions to NICE and the Scottish Medicines Consortium. Professor Mike Drummond | Professor…
Dr Tuba Saygın Avşar
26 January 2024
Tuba is a health economist and science policy adviser. She currently works as a Scientific Adviser at the National Institute for Health and Care Excellence (NICE). Tuba has over ten…